Clinic
Kenaitze Indian Tribe
Kenaitze Indian Tribe was paid $13.86M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 33% of everything it billed.
33Billing provider infoKENAITZE INDIAN TRIBE
KENAI, AK 99611
KENAI, AK 99611
33aNPI1932114600assigned 07/30/2006
33bProvider typeClinic/Center
28Total paid$13.86M
24GClaims53,039
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Alaska
Rank by total paid#3 of 41
Median peer was paid$266K
This provider vs. median52×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,382 | $1.19M | |
| 2019 | 7,903 | $1.94M | |
| 2020 | 5,251 | $1.55M | |
| 2021 | 7,274 | $2.44M | |
| 2022 | 9,237 | $2.51M | |
| 2023 | 11,223 | $2.07M | |
| 2024incomplete | 7,769 | $2.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 13,074 | 10,566 | $4.61M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 6,464 | 5,182 | $1.88M |
| 80053 | Comprehensive metabolic panel | 9.2% | 2,558 | 2,186 | $1.27M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 7.9% | 1,849 | 1,402 | $1.09M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 6.1% | 1,672 | 1,535 | $841K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.8% | 1,363 | 1,067 | $799K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.0% | 1,401 | 564 | $551K |
| 99441 | 3.6% | 1,055 | 902 | $493K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 897 | 813 | $408K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.9% | 1,438 | 1,078 | $405K |
| 81003 | 2.8% | 1,497 | 1,324 | $386K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.7% | 430 | 402 | $231K |
40 more codes
| 99442 | <1% | 235 | $120K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 409 | $82K |
| 0002A | <1% | 105 | $78K | |
| 81001 | <1% | 367 | $76K | |
| 0001A | <1% | 95 | $67K | |
| 92015 | Determination of refractive state | <1% | 2,763 | $66K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 756 | $63K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 132 | $42K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,511 | $42K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,769 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,476 | $32K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 79 | $28K |
| 80061 | Lipid panel | <1% | 647 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,490 | $22K |
| 85018 | <1% | 41 | $21K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 173 | $17K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 111 | $17K |
| 0071A | <1% | 12 | $10K | |
| 0012A | <1% | 12 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $7K |
| 84439 | <1% | 482 | $6K | |
| 82607 | <1% | 624 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 19 | $5K |
| 87400 | <1% | 17 | $4K | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 614 | $4K |
| 99173 | <1% | 16 | $3K | |
| 81025 | <1% | 31 | $1K | |
| 83721 | <1% | 633 | $862.00 | |
| 84481 | <1% | 471 | $712.00 | |
| 82570 | 0% | 189 | $0.00 | |
| 90756 | 0% | 18 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 13 | $0.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 28 | $0.00 |
| 83735 | 0% | 326 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,710 | $0.00 |
| 97124 | 0% | 356 | $0.00 | |
| 99000 | 0% | 361 | $0.00 | |
| 82043 | 0% | 189 | $0.00 | |
| 91307 | 0% | 32 | $0.00 | |
| 92310 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBURNETT, GREG (FINANCE DIRECTOR)
Parent organizationKENAITZE INDIAN TRIBE
| Provider | Location | Paid |
|---|---|---|
| Kenaitze Indian Tribe | Kenai, AK | $41.44M |
| Kenaitze Indian Tribe | Kenai, AK | $3.16M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.